STAT

Opinion: ‘Deep medicine’ will help everyone, especially people like me with a rare disease

AI won't replace doctors but will free them up to operate at the apex of their professional mission: humanistic interactions and relationships with those in their care.

Two things I read recently gave me hope for the future of medicine and the future of people like me with rare or difficult-to-diagnose diseases.

One was the article “Calculation of a Primary Immunodeficiency ‘Risk Vital Sign’ via Population-Wide Analysis of Claims Data to Aid in Clinical Decision Support” in the journal Frontiers in Pediatrics. Not a sexy title, I know, but stick with me here. The other was Eric Topol’s newest book, “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.”

These two related works resonated with me because I have a rare disease called . In this mostly genetic disorder, protective antibodies are either seriously lacking or entirely absent, leaving individuals susceptible to all types of infections, many of which have the potential to become life-threatening. This dearth of antibodies also leads

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related